Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Sirolimus in LAM

ClinicalTrials.gov ID: NCT00414648

Public ClinicalTrials.gov record NCT00414648. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus Trial

Study identification

NCT ID
NCT00414648
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Cincinnati
Other
Enrollment
89 participants

Conditions and interventions

Interventions

  • Sirolimus Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2006
Primary completion
Aug 31, 2010
Completion
Jan 31, 2011
Last update posted
Nov 1, 2023

2006 – 2011

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
University of California Los Angeles Los Angeles California 90024
National Jewish Medical and Research Center Denver Colorado 80206
University of Florida, Gainesville Gainesville Florida 32611
National Heart, Lung, and Blood Institute Bethesda Maryland 20892
Harvard's Brigham and Women's Hospital Boston Massachusetts 02115
University of Cincinnati Medical Center Cincinnati Ohio 45267
Cleveland Clinic Foundation Cleveland Ohio 44195
Oregon Health & Science University Portland Oregon 97239
Medical University of South Carolina Charleston South Carolina 29425
University of Texas Health Center at Tyler Tyler Texas 75708

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00414648, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00414648 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →